Robert A. Ortenzio - 14 Dec 2023 Form 4 Insider Report for SELECT MEDICAL HOLDINGS CORP (SEM)

Role: EXECUTIVE CHAIRMAN, Director
Signature: /s/ Michael E. Tarvin, Attorney-in-Fact
Issuer symbol: SEM
Transactions as of: 14 Dec 2023
Net transactions value: -$2,500,000
Form type: 4
Filing time: 14 Dec 2023, 16:57:20 UTC
Previous filing: 11 Sep 2023
Next filing: 09 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SEM	Common Stock	Sale	$2,500,000	-100,000	-1.4%	$25.00	6,939,668	14 Dec 2023	Direct	F1
holding	SEM	Common Stock						1,279,000	14 Dec 2023	By the Robert A. Ortenzio Descendants Trust	F2
holding	SEM	Common Stock						3,804,805	14 Dec 2023	By the Rocco A. Ortenzio Separate Exempt Descendants Trust	F2
holding	SEM	Common Stock						280,415	14 Dec 2023	By the Robert A. Ortenzio 2014 Trust for Bryan A. Ortenzio	F2
holding	SEM	Common Stock						280,415	14 Dec 2023	By the Robert A. Ortenzio 2014 Trust for Kevin M. Ortenzio	F2
holding	SEM	Common Stock						280,415	14 Dec 2023	By the Robert A. Ortenzio 2014 Trust for Madeline G. Ortenzio	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	These shares were sold pursuant to a 10b5-1 trading plan adopted by Robert A. Ortenzio on December 9, 2022.
F2	The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.